Oppenheimer & CO Inc Edwards Lifesciences Corp Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Oppenheimer & CO Inc holds 38,186 shares of EW stock, worth $2.53 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

38,186

Previous 36,745 3.92%

Holding current value

$2.53 Million

Previous $3.39 Million 25.78%

% of portfolio

0.04%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$59.7 - $93.78 $86,027 - $135,136	1,441 Added 3.92%	38,186 $2.52 Million
Q2 2024 Aug 07, 2024	BUY	$84.3 - $94.31 $884,475 - $989,500	10,492 Added 39.96%	36,745 $3.39 Million
Q1 2024 May 06, 2024	BUY	$72.54 - $95.56 $361,031 - $475,602	4,977 Added 23.39%	26,253 $2.51 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $667,270 - $840,818	-10,813 Reduced 33.7%	21,276 $1.62 Million
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $447,756 - $603,514	-6,463 Reduced 16.76%	32,089 $2.22 Million
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $85,480 - $99,046	-1,050 Reduced 2.65%	38,552 $3.64 Million
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $1.39 Million - $1.59 Million	-18,758 Reduced 32.14%	39,602 $3.28 Million
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $999,570 - $1.28 Million	14,635 Added 33.47%	58,360 $4.35 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $132,450 - $172,522	-1,608 Reduced 3.55%	43,725 $3.61 Million
Q2 2022 Aug 08, 2022	BUY	$86.5 - $128.27 $190,473 - $282,450	2,202 Added 5.11%	45,333 $4.31 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $113,991 - $143,484	-1,118 Reduced 2.53%	43,131 $5.08 Million
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $194,231 - $238,621	1,826 Added 4.3%	44,249 $5.73 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $202,732 - $241,817	1,970 Added 4.87%	42,423 $4.8 Million
Q2 2021 Aug 03, 2021	SELL	$83.84 - $104.76 $356,906 - $445,963	-4,257 Reduced 9.52%	40,453 $4.19 Million
Q1 2021 May 10, 2021	SELL	$78.68 - $90.67 $1.05 Million - $1.21 Million	-13,309 Reduced 22.94%	44,710 $3.74 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $259,804 - $330,617	-3,624 Reduced 5.88%	58,019 $5.29 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $848,744 - $1.1 Million	12,632 Added 25.77%	61,643 $4.92 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $1.67 Million - $2.23 Million	28,991 Added 144.81%	49,011 $3.39 Million
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $397,791 - $614,790	7,590 Added 61.06%	20,020 $3.78 Million
Q4 2019 Feb 07, 2020	BUY	$71.7 - $82.09 $168,710 - $193,157	2,353 Added 23.35%	12,430 $2.9 Million
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $111,836 - $137,056	-1,817 Reduced 15.28%	10,077 $2.22 Million
Q2 2019 Aug 09, 2019	SELL	$55.74 - $64.41 $310,248 - $358,506	-5,566 Reduced 31.88%	11,894 $2.2 Million
Q1 2019 Apr 24, 2019	SELL	$47.89 - $64.05 $40,658 - $54,378	-849 Reduced 4.64%	17,460 $3.34 Million
Q4 2018 Jan 29, 2019	BUY	$46.41 - $56.94 $66,273 - $81,310	1,428 Added 8.46%	18,309 $2.8 Million
Q3 2018 Oct 26, 2018	BUY	$45.7 - $58.03 $151,906 - $192,891	3,324 Added 24.52%	16,881 $2.94 Million
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $256,313 - $309,749	-6,038 Reduced 30.81%	13,557 $1.97 Million
Q1 2018 May 01, 2018	SELL	$37.19 - $47.45 $16,586 - $21,162	-446 Reduced 2.23%	19,595 $2.73 Million
Q4 2017 Feb 07, 2018	BUY	$33.79 - $39.39 $344,353 - $401,423	10,191 Added 103.46%	20,041 $2.26 Million
Q3 2017 Nov 09, 2017	BUY	$36.29 - $38.83 $357,456 - $382,475	9,850	9,850 $1.08 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

6.35M

Put Options Held

2.82M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Edwards Lifesciences Corp Transaction History